Revision History

1 revisions for "After a Devastating Flu Season, FDA Advisers Unanimously Vote to Target Subclade K in Next Fall's Vaccines"

Anonymous21 days ago

The FDA's Vaccines and Related Biological Products Advisory Committee voted 7-0 on March 12, 2026, to recommend that 2026-2027 influenza vaccines include strains targeting subclade K, the H3N2 variant that dominated the current season and evaded the mismatched 2025-2026 flu shot. The decision comes after a punishing flu season that has caused an estimated 27 million illnesses, 350,000 hospitalizations, and 22,000 deaths — and amid broader political tensions over the FDA's vaccine advisory process under Commissioner Martin Makary.